{"id":"NCT00309738","sponsor":"Kowa Research Europe","briefTitle":"Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin","officialTitle":"Study of Pitavastatin Vs. Simvastatin (Following Up-Titration) in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia and 2 or More Risk Factors for Coronary Heart Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-09","primaryCompletion":"2006-10","completion":"2006-10","firstPosted":"2006-04-03","resultsPosted":"2010-01-18","lastUpdate":"2010-03-16"},"enrollment":355,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia","Dyslipidemia"],"interventions":[{"type":"DRUG","name":"pitavastatin","otherNames":[]},{"type":"DRUG","name":"simvastatin","otherNames":[]}],"arms":[{"label":"Pitavastatin 4 mg QD","type":"EXPERIMENTAL"},{"label":"Simvastatin 40 mg QD","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the efficacy and safety of pitavastatin with that of simvastatin in patients with risk factors for heart disease.","primaryOutcome":{"measure":"Percent Change From Baseline in LDL-C","timeFrame":"12 weeks","effectByArm":[{"arm":"Pitavastatin 4 mg QD","deltaMin":-43.96,"sd":12.77},{"arm":"Simvastatin 40 mg QD","deltaMin":-43.77,"sd":14.416}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":35,"countries":["Denmark","Netherlands","Spain","Sweden"]},"refs":{"pmids":["21874538"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4},"commonTop":["Headache","Nasopharyngitis","Consitpation","Myalgia","Hypertension"]}}